EP2549984 - DOUBLE-LAYER PHARMACEUTICAL FORMULATIONS CONTAINING OPIOID AGONISTS AND ANTAGONISTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.01.2016 Database last updated on 17.05.2024 | Most recent event Tooltip | 12.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states L. MOLTENI & C. DEI FRATELLI ALITTI - SOCIETA' DI ESERCIZIO S.P.A. Strada Statale 67 Tosco-Romagnola Località Granatieri 50018 Scandicci / IT | [2014/22] |
Former [2013/05] | For all designated states Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. Strada Statale 67 Tosco-Romagnola Localita Granatieri 50018 Scandicci / IT | Inventor(s) | 01 /
ANGELI, Roberto Via dell'Acciaiolo 44 I-50018 Scandicci / IT | 02 /
RAFFAELI, William Via Giarabub 30 I-47923 Rimini / IT | 03 /
RIGAMONTI, Maria Adele Via Locchi 90 I-50145 Firenze / IT | [2013/05] | Representative(s) | Brighenti, Livio, et al NOTARBARTOLO & GERVASI S.p.A. Corso di Porta Vittoria, 9 20122 Milano / IT | [N/P] |
Former [2013/05] | Brighenti, Livio, et al NOTARBARTOLO & GERVASI S.p.A. Corso di Porta Vittoria, 9 20122 Milano / IT | Application number, filing date | 11716189.3 | 23.03.2011 | WO2011EP54463 | Priority number, date | IT2010FI00047 | 24.03.2010 Original published format: IT FI20100047 | [2013/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011117306 | Date: | 29.09.2011 | Language: | EN | [2011/39] | Type: | A1 Application with search report | No.: | EP2549984 | Date: | 30.01.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.09.2011 takes the place of the publication of the European patent application. | [2013/05] | Type: | B1 Patent specification | No.: | EP2549984 | Date: | 18.03.2015 | Language: | EN | [2015/12] | Search report(s) | International search report - published on: | EP | 29.09.2011 | Classification | IPC: | A61K9/24, A61K31/485 | [2014/43] | CPC: |
A61K9/209 (EP,US);
A61K31/485 (EP,US);
A61P25/04 (EP)
|
Former IPC [2013/05] | A61K9/20, A61K31/485 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/05] | Extension states | BA | 22.10.2012 | ME | 22.10.2012 | Title | German: | DOPPELSCHICHTIGE PHARMAZEUTISCHE FORMULIERUNGEN MIT OPIOID-ANTAGONISTEN UND ANTAGONISTEN | [2013/05] | English: | DOUBLE-LAYER PHARMACEUTICAL FORMULATIONS CONTAINING OPIOID AGONISTS AND ANTAGONISTS | [2013/05] | French: | PRÉPARATIONS PHARMACEUTIQUES DOUBLE-COUCHE CONTENANT DES AGONISTES ET DES ANTAGONISTES DES RÉCEPTEURS OPIOÏDES | [2013/05] | Entry into regional phase | 22.10.2012 | National basic fee paid | 22.10.2012 | Designation fee(s) paid | 22.10.2012 | Examination fee paid | Examination procedure | 22.10.2012 | Amendment by applicant (claims and/or description) | 22.10.2012 | Examination requested [2013/05] | 14.10.2013 | Despatch of a communication from the examining division (Time limit: M06) | 31.03.2014 | Reply to a communication from the examining division | 01.10.2014 | Communication of intention to grant the patent | 02.02.2015 | Fee for grant paid | 02.02.2015 | Fee for publishing/printing paid | 02.02.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.10.2013 | Opposition(s) | 21.12.2015 | No opposition filed within time limit [2016/08] | Fees paid | Renewal fee | 11.02.2013 | Renewal fee patent year 03 | 06.02.2014 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 23.03.2011 | AL | 18.03.2015 | AT | 18.03.2015 | BG | 18.03.2015 | CY | 18.03.2015 | CZ | 18.03.2015 | DK | 18.03.2015 | EE | 18.03.2015 | FI | 18.03.2015 | HR | 18.03.2015 | IT | 18.03.2015 | LT | 18.03.2015 | LV | 18.03.2015 | MC | 18.03.2015 | MK | 18.03.2015 | MT | 18.03.2015 | RO | 18.03.2015 | RS | 18.03.2015 | SE | 18.03.2015 | SI | 18.03.2015 | SK | 18.03.2015 | SM | 18.03.2015 | TR | 18.03.2015 | LU | 23.03.2015 | CH | 31.03.2015 | LI | 31.03.2015 | NO | 18.06.2015 | IS | 18.07.2015 | [2018/46] |
Former [2018/31] | HU | 23.03.2011 | |
AT | 18.03.2015 | ||
BG | 18.03.2015 | ||
CY | 18.03.2015 | ||
CZ | 18.03.2015 | ||
DK | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
MK | 18.03.2015 | ||
MT | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SI | 18.03.2015 | ||
SK | 18.03.2015 | ||
SM | 18.03.2015 | ||
TR | 18.03.2015 | ||
LU | 23.03.2015 | ||
CH | 31.03.2015 | ||
LI | 31.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2018/02] | HU | 23.03.2011 | |
AT | 18.03.2015 | ||
BG | 18.03.2015 | ||
CY | 18.03.2015 | ||
CZ | 18.03.2015 | ||
DK | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
MT | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SI | 18.03.2015 | ||
SK | 18.03.2015 | ||
SM | 18.03.2015 | ||
TR | 18.03.2015 | ||
LU | 23.03.2015 | ||
CH | 31.03.2015 | ||
LI | 31.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2017/38] | HU | 23.03.2011 | |
AT | 18.03.2015 | ||
BG | 18.03.2015 | ||
CY | 18.03.2015 | ||
CZ | 18.03.2015 | ||
DK | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
MT | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SI | 18.03.2015 | ||
SK | 18.03.2015 | ||
SM | 18.03.2015 | ||
TR | 18.03.2015 | ||
CH | 31.03.2015 | ||
LI | 31.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2017/03] | AT | 18.03.2015 | |
CZ | 18.03.2015 | ||
DK | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
MT | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SI | 18.03.2015 | ||
SK | 18.03.2015 | ||
CH | 31.03.2015 | ||
LI | 31.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2016/12] | AT | 18.03.2015 | |
CZ | 18.03.2015 | ||
DK | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SI | 18.03.2015 | ||
SK | 18.03.2015 | ||
CH | 31.03.2015 | ||
LI | 31.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2016/07] | AT | 18.03.2015 | |
CZ | 18.03.2015 | ||
DK | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SK | 18.03.2015 | ||
CH | 31.03.2015 | ||
LI | 31.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2016/06] | AT | 18.03.2015 | |
CZ | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SK | 18.03.2015 | ||
CH | 31.03.2015 | ||
LI | 31.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2016/03] | AT | 18.03.2015 | |
CZ | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
IT | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SK | 18.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2015/51] | AT | 18.03.2015 | |
CZ | 18.03.2015 | ||
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SK | 18.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2015/50] | CZ | 18.03.2015 | |
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SK | 18.03.2015 | ||
NO | 18.06.2015 | ||
IS | 18.07.2015 | ||
Former [2015/49] | CZ | 18.03.2015 | |
EE | 18.03.2015 | ||
FI | 18.03.2015 | ||
HR | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
RO | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
SK | 18.03.2015 | ||
NO | 18.06.2015 | ||
Former [2015/39] | FI | 18.03.2015 | |
HR | 18.03.2015 | ||
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
RS | 18.03.2015 | ||
SE | 18.03.2015 | ||
NO | 18.06.2015 | ||
Former [2015/36] | FI | 18.03.2015 | |
HR | 18.03.2015 | ||
LT | 18.03.2015 | ||
SE | 18.03.2015 | ||
NO | 18.06.2015 | ||
Former [2015/35] | LT | 18.03.2015 | |
NO | 18.06.2015 | Cited in | International search | [A]DE4325465 (ZENZ MICHAEL PROF DR MED [DE], et al) [A] 1-10 * claim - * * example - *; | [AD]WO9602251 (EINSTEIN COLL MED [US]) [AD] 1-10* claim - *; | [AD]WO03013538 (EURO CELTIQUE SA [LU], et al) [AD] 1-10 * claim - * * example - *; | [A]WO2004037260 (GRUENENTHAL GMBH [DE], et al) [A] 1-10 * claim - * * example - * | Examination | WO9733566 | by applicant | WO9602251 | US5580876 | WO2005107726 | EP1935421 |